Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03033602 · ClinicalTrials.gov registry record · NA
Brief Treatment for Posttraumatic Stress Disorder
A NA study, sponsored by Boston VA Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 169
- Enrollment target
NCT03033602 is a NA study that has completed, run by Boston VA Research Institute. The registered enrollment target is 169 participants.
The verdict
NCT03033602, a NA study, has completed, sponsored by Boston VA Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 169 participants
- Enrollment target
Study Summary
The primary goal of this study is to examine whether a brief treatment approach for PTSD is equally efficacious in the treatment of active duty service members relative to a first line treatment approach that requires much greater treatment dose.
Interventions
- BEHAVIORAL written exposure therapy
- BEHAVIORAL CPT, cognitive only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 169 participants |
| Start Date | 2015-07-20 |
| Est. Completion | 2021-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03033602
The ClinicalTrials.gov registry entry for NCT03033602 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 169 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston VA Research Institute, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which written exposure therapy is the first listed.
NCT03033602 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03033602 about?
NCT03033602 is a clinical study titled "Brief Treatment for Posttraumatic Stress Disorder". The primary goal of this study is to examine whether a brief treatment approach for PTSD is equally efficacious in the treatment of active duty service members relative to a first line treatment approach that requires much greater treatment dose.
What is the current status of trial NCT03033602?
This trial is currently completed. It is a NA study. The enrollment target is 169 participants. The study started on 2015-07-20. Estimated completion is 2021-03-31.
What interventions are being tested in trial NCT03033602?
The interventions under investigation include: written exposure therapy (BEHAVIORAL), CPT, cognitive only (BEHAVIORAL).
Who is sponsoring clinical trial NCT03033602?
This trial is sponsored by Boston VA Research Institute, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.